We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LTRN market cap is 55.43M. The company's latest EPS is USD -1.4686 and P/E is -3.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.15M | -3.83M | -4.29M | -5.19M | -3.52M |
| Net Income | -2.27M | -3.38M | -3.87M | -4.75M | -3.16M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.43M | -5.91M | -12.59M | -14.43M | -17.88M |
| Net Income | -2.43M | -5.91M | -12.36M | -14.26M | -15.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 62.16M | 58.84M | 55.51M | 51.43M | 47.77M |
| Total Liabilities | 3.14M | 2.8M | 2.93M | 3.17M | 2.36M |
| Total Equity | 59.03M | 56.04M | 52.58M | 48.26M | 45.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.43M | 20.36M | 73.95M | 58.84M | 43.65M |
| Total Liabilities | 490k | 661k | 2.38M | 2.8M | 2.74M |
| Total Equity | 943k | 19.7M | 71.57M | 56.04M | 40.91M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.1M | -12.77M | -3.76M | -7.35M | -10.96M |
| Investing | -424k | 179k | -961k | -1.42M | -1.19M |
| Financing | -2.18M | -2.18M | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.13M | -5.65M | -10.59M | -12.77M | -14.35M |
| Investing | -6k | -16k | -19.53M | 179k | -930k |
| Financing | 2.92M | 23.67M | 63.42M | -2.18M | -500k |
| Market Cap | 55.43M |
| Price to Earnings Ratio | -3.47 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.53 |
| Price to Book Ratio | 1.36 |
| Dividend Yield | - |
| Shares Outstanding | 10.87M |
| Average Volume (1 week) | 147.24k |
| Average Volume (1 Month) | 212.56k |
| 52 Week Change | 3.87% |
| 52 Week High | 11.99 |
| 52 Week Low | 2.38 |
| Spread (Intraday) | 1.18 (18.79%) |
| Company Name | Lantern Pharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
